Skip to content
PreclinicalResearch compoundModerate evidence

AVL‑3288

Experimental compound that boosts the brain's acetylcholine signal: improved memory in animals, not proven in humans.

NootropicCholinergicCholinergicMemoryAcetylcholinenoo.affects.cholinergic

Pharmacology

ClassCholinergic · Memory
Primary targetα7 nicotinic acetylcholine receptor type-I positive allosteric modulation
Targets3 receptor targets
Half-lifeConsistent single-dose pharmacokinetics in Phase 1 trials (precise human half-life not reported)
OnsetStudied as a single daily oral dose (no precise human onset data)
EvidenceModerate evidence
Affected systemsAcetylcholinenoo.affects.cholinergic

Contents

DETAILED OVERVIEW

What is AVL-3288?

AVL-3288 (also known as UCI-4083 or XY-4083) is an experimental compound that researchers are studying to improve memory and thinking. It is not approved as a medicine anywhere and is not sold as a supplement. So far it has been studied mainly in animals and has not been proven in humans.

It does not switch on one of the nerve cell receptors directly; instead it strengthens the effect of the brain's own messenger, acetylcholine, on it. In rodents it improved learning and memory, reduced autism-like behavior and eased the learning and memory problems that follow a head injury. In humans it has been tested in only a limited number of studies: it was found safe and well tolerated, but in a study of people with schizophrenia it worked no better than placebo. Its long-term safety is unknown, its safety in pregnancy and breastfeeding has not been established, and its effects may add up with other drugs that act on acetylcholine.

Mechanism

α7 nAChR type-I PAM

Evidence

Human Phase 1 + schizophrenia RCT (efficacy negative)

Legal status

Investigational, not approved

Receptor profile

  • α7 nicotinic acetylcholine receptorsStrong
  • Acetylcholine signalingModerate
  • Type-I PAM (preserves desensitization)Moderate

Safety

Side effects, stop signs, contraindications

Side effects · 4

  • In Phase 1 human trials it was safe and well tolerated, with no reported safety concerns
  • Theoretical symptoms of cholinergic overstimulation (nausea, headache, dizziness) typical of the class
  • In a randomized trial in schizophrenia patients it showed no cognitive benefit over placebo
  • Limited number of human trials: long-term safety in humans is not fully characterized

Contraindications · 3

  • Pregnancy and breastfeeding: safety not established, avoid
  • Unapproved, investigational compound; not recommended outside clinical supervision
  • Caution with other cholinergic agents (cholinesterase inhibitors, nicotinic agonists) due to additive effects

Related Nootropics

Same therapeutic category

Studies

Related research and clinical findings

FAQ

FAQ

AVL-3288 is an experimental compound being studied as a potential memory and cognition booster. In animal studies it improved learning and memory and even helped with memory problems after brain injury, but in humans it has only gone through the earliest, safety-focused testing stage, so there's very little real human experience with it. It's not available or intended for practical use, it's purely a research subject at this point.

Telegram

Have a question about AVL‑3288?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeNootropic
FormulaC19H15Cl2N3O2
UpdatedOctober 13, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 13, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.